SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing renewed market attention driven by its institutional-grade post-quantum security features and its classification as a digital commodity. While the community remains divided between long-term holders optimistic about its real-world asset tokenization potential and bears focused on historic price performance, active discussions highlight a surge in trading volume and increased social dominance.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is attracting significant community attention as traders debate its potential for a breakout, with many highlighting the upcoming Layla upgrade in May 2026 as a pivotal catalyst for increased utility and quantum resistance. While bulls point to resilient price action and the network's low-fee, peer-to-peer focus, ongoing discussions remain polarized between those expecting a major decoupling from Bitcoin and critics dismissing the asset due to historical performance concerns.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibb is currently trending as investors focus on the company's oncology pipeline expansion and recent positive data, while also monitoring potential M&A activity within the sector. Community sentiment remains mixed as traders analyze the balance between long-term dividend stability and the upcoming challenges posed by major patent expirations.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to heightened investor focus on the upcoming PDUFA decision date for RP1, with market participants debating whether the resubmission successfully addresses previous FDA concerns or if a second Complete Response Letter is likely. The community remains deeply divided, with some traders citing unusual options volume and potential short-covering as bullish indicators, while skeptics warn of significant downside risk if the company fails to secure accelerated approval.

Maul Coin

Maul Coin is generating buzz as a community-driven project aiming to replicate the massive growth of previous viral memecoins through active social media raiding and a transparent developer-led approach. While the community is currently focused on overcoming technical hurdles like securing official charts and listings, members are heavily incentivized by the potential for 1000x gains and a movement-based ethos that rejects typical 'pump and dump' behavior.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently trending as investors rotate into high-quality dividend compounders, with the community closely tracking recent FDA approvals and positive oncology pipeline data. Sentiment is further bolstered by analyst upgrades and confidence in the company's defensive strength as market participants navigate broader volatility.

U.S. Gold Corp. engages in the exploration of gold properties. It has properties in CK Gold Project, Wyoming, Challis Gold Project, Idaho, and Keystone, Nevada. The company was founded in 1967 and is headquartered in Elko, NV.

U.S. Gold Corp

U.S. Gold Corp ($USAU) is trending as investors focus on its near-term catalysts, including its upcoming inclusion in the Russell index and the highly anticipated completion of a feasibility study for the CK Gold Project. While community members highlight the project's de-risking and potential for institutional inflows, discussions are also dominated by concerns over the high volume of automated accounts pumping the stock.

Norfolk Southern Corp. is a transportation company, which engages in the rail transportation of raw materials, intermediate products, and finished goods. The company also transports overseas freight through several Atlantic and Gulf Coast ports. Its services include property leases and sales, wire line or pipeline and fiber optics projects, access property, managing private crossings, promoting businesses with signboards, and natural resource management. The company was founded on July 23, 1980, and is headquartered in Atlanta, GA.

Norfolk Southern Corp.

Norfolk Southern Corp. is currently under investor scrutiny as it navigates complex regulatory, legal, and operational headwinds following the East Palestine incident and a series of leadership and labor contract challenges. Market conversation is heavily centered on the company's valuation, the impact of potential industry-wide consolidation, and the ongoing tension between management strategies and activist investor efforts to overhaul governance.

Invesco DB US Dollar Index Bullish Fund - Common units of beneficial interest

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund is currently trending as markets weigh escalating trade tensions and geopolitical uncertainty against conflicting labor data and shifting Federal Reserve rate expectations. Investors are actively debating the dollar's role as a safe-haven asset amidst potential policy realignments, currency intervention risks, and ongoing debates over U.S. fiscal deficits and de-dollarization.

iShares Trust - iShares Russell 2000 Value ETF

iShares Russell 2000 Value ETF

The iShares Russell 2000 Value ETF (IWN) is trending as investors monitor ongoing Federal Reserve policy debates and geopolitical volatility, with many community members focusing on the index as a bellwether for small-cap performance. Traders are actively discussing the potential for a rotation into value-oriented small-cap equities, frequently using IWN and the Russell 2000 to gauge market breadth and position against broader index trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Zevia PBC (NYSE:ZVIA) Given Average Rating of "Hold" by Brokerages

Shares of Zevia PBC (NYSE:ZVIA - Get Free Report) have earned an average recommendation of "Hold" from the six analysts that are currently covering the stock, MarketBeat Ratings reports. One analyst...

Zevia PBC (NYSE:ZVIA) Sees Large Decline in Short Interest

Zevia PBC (NYSE:ZVIA - Get Free Report) saw a significant decrease in short interest in March. As of March 13th, there was short interest totaling 2,611,157 shares, a decrease of 13.8% from the February 26th total of 3,030,263 shares. Currently, 3.9% of the company's shares are short sold. Based...

Girish Satya Sells 41,662 Shares of Zevia PBC (NYSE:ZVIA) Stock

Zevia PBC (NYSE:ZVIA - Get Free Report) CFO Girish Satya sold 41,662 shares of the business's stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $1.18, for a...

ZEVIA AND CARDI B ANNOUNCE PARTNERSHIP ROOTED IN RADICAL REALNESS

ZEVIA AND CARDI B ANNOUNCE PARTNERSHIP ROOTED IN RADICAL REALNESS ZEVIA AND CARDI B ANNOUNCE PARTNERSHIP ROOTED IN RADICAL REALNESS PR Newswire LOS ANGELES, March 20, 2026 Grammy-Winning Artist Joins...

Zevia PBC (NYSE:ZVIA) Sees Large Growth in Short Interest

Zevia PBC (NYSE:ZVIA - Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 3,030,263 shares, a...

Divisadero Street Capital Management LP Acquires 2,928,382 Shares of Zevia PBC $ZVIA

Divisadero Street Capital Management LP boosted its holdings in Zevia PBC (NYSE:ZVIA - Free Report) by 90.6% in the third quarter, according to its most recent 13F filing with the Securities and...

Ghisallo Capital Management LLC Has $2.99 Million Stock Position in Zevia PBC $ZVIA

Ghisallo Capital Management LLC boosted its holdings in shares of Zevia PBC (NYSE:ZVIA - Free Report) by 265.1% in the 3rd quarter, according to its most recent disclosure with the Securities and...

Zevia PBC (NYSE:ZVIA) Receives Average Recommendation of "Hold" from Brokerages

Zevia PBC (NYSE:ZVIA - Get Free Report) has been given a consensus recommendation of "Hold" by the six brokerages that are currently covering the firm, Marketbeat reports. One investment analyst has...

Zevia PBC Q4 Earnings Call Highlights

Zevia PBC (NYSE:ZVIA) executives said the company made transformation progress in 2025, pointing to improved profitability metrics, expanded distribution, and a stepped-up innovation and marketing...

Zevia PBC (NYSE:ZVIA) Posts Earnings Results, Beats Estimates By $0.01 EPS

Zevia PBC (NYSE:ZVIA - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.01. Zevia...

Zevia PBC engages in the provision of development, marketing, sales, and distribution of zero-calorie diet sodas. Its products include soda, energy, organix tea, mixers, kidz drinks, and sparkling water. The company was founded in 2007 and is headquartered in Los Angeles, CA.

Zevia PBC - Ordinary Shares - Class A

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$1.20
Prev Close	$1.17
Open	$1.15
Dividend Yield	0.00%
50-Day Moving Average	$1.50
Beta	1.33
Avg. Volume	574,358.32
PE Ratio	-7.82

52-Week High	$3.66
52-Week Low	$1.11
Market Capitalization	$90.12M
EPS (Annual)	-$0.1527
Price to Book	1.59
Revenue Per Employee	$1.77M

ZVIA
Zevia PBC - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ZVIA News

ZVIAZevia PBC - Ordinary Shares - Class A